纵横研报
Ticker Detail

002252.SHE

¥4.93+2.49% 上海莱士 Biotechnology
00Reports China 医疗健康
Shanghai RAAS Blood Products Co Ltd Class A
医疗健康 · 生物科技

Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinogen; FIBINGLURAAS, a fibrin sealant for humans; and THROMBIRAAS, a human thrombin product. It also provides specific immune, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin, hepatitis B human immunoglobulin, and other blood products. The company exports its products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is headquartered in Shanghai, China.

MARKET 市值 30.46B CNY PE 23.1x Fwd 112.4x 52W ¥4.18 – ¥7.19 EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG 营收 YoY -24.7% ROE 4.1% 营业利润率 21.6% 净利润率 19.4%
ANALYST 股息率 1.05%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制